Washington, July 1 -- Congresswoman Doris Matsui issued the following press release:
Today, Congresswoman Doris Matsui (D-CA) and Congressman Jack Bergman (R-MI) led a bipartisan group of 72 total members of Congress in demanding that the Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) take immediate action to stop Eli Lilly and Company from unlawfully conditioning access to 340B drug discounts.
"We write to express our serious concern regarding the recent action by Eli Lilly and Company (Lilly) terminating 340B pricing for covered entities' (CE) that do not comply with its in-house claims data policy," wrote the lawmakers.
"Congress established 340B to enable safety-net providers t...